NJAAIS 2016 Annual Teaching Day

Long Branch, NJ US
September 9, 2016

NJAAIS is a non-profit professional organization of practicing allergists and immunologists and fellows-in-training. Once per year the society gathers for an annual teaching day. Lectures include new and up to date information in the allergy and immunology field to further the knowledge of all physicians in attendance. 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the New Jersey Allergy, Asthma and Immunology Society (NJAAIS).  The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support

No commercial support for this activity.

Target Audience

Allergists and Allied Health Professionals

 

Learning Objectives

At the conclusion of this activity, participants should be able to:

(1) Compare and contrast similarities and differences between wheat allergy & wheat intolerance

(2) Explain how to prevent and manage complications of CVID

(3) Review new advancements in asthma management

(4) Explain how to use complementive alternative medicine within a traditional allergy practice

(5) Explain how to diagnose and treat non IgE mediated drug allergy

(6) Identify current treatment of oral IT 

Additional information
Disclosure: 

Disclosures

NJAAIS 2016 Annual Meeting

September 9, 2016 * Long Branch, NJ

 

Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

 

All identified conflicts of interest have been resolved.

 

▲Jordan Orange, MD      

   Advisory Board: Baxalta, CSL Behring, Biotest, Walgreens,

   ASD Healthcare, ADMA Biologics, Grifols

   Research Grants: CSL Behring

   Honorarium: Baxalta

 
▲David Khan, MD     

  Speaker: Genentech

  Honorarium: Genentech, UpToDate

  Advisory Board: Aimmune

  Research Grant: NIH

 

▲ Corinne Keet, MD

  Consulting: Environmental Defense Fund Non-Profit

  

▲Sami Bahna, MD

  Consulting: Clarion Healthcare

  Advisory Board: Clarion Healthcare

 

▲William Silvers, MD

  Speaker: Teva, Meda


▲Rohit Katial, MD

  Advisory Board: Astra Zeneca, Boehringer, Meda, Teva

  Grant: Astra Zeneca, Teva, GSK

  Speaker: Meda, Teva  

 

 

 

 

 

 

 

 

 

 

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
Course opens: 
09/09/2016
Course expires: 
09/09/2018
Event starts: 
09/09/2016 - 8:00am CDT
Event ends: 
09/09/2016 - 4:30pm CDT
Add to calendar: 
Rating: 
0
Ocean Place
1 Ocean Blvd.
Long Branch, NJ 07740
United States

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the New Jersey Allergy, Asthma and Immunology Society (NJAAIS).  The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
Please login or create an account to take this course.